We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
Cap. Flow
+$8.89B
Cap. Flow %
8.09%
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.35B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.85B
3
LLY icon
Eli Lilly
LLY
+$999M
4
KO icon
Coca-Cola
KO
+$685M
5
AVGO icon
Broadcom
AVGO
+$616M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.38B
2
AAPL icon
Apple
AAPL
+$1.12B
3
NFLX icon
Netflix
NFLX
+$678M
4
BSX icon
Boston Scientific
BSX
+$671M
5
COR icon
Cencora
COR
+$627M

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Consumer Discretionary 12.77%
3 Healthcare 10.45%
4 Financials 7.74%
5 Communication Services 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHI icon
626
National Health Investors
NHI
$3.65B
$19.1M 0.02%
249,949
-52,478
-17% -$4.02M
OLLI icon
627
Ollie's Bargain Outlet
OLLI
$4.94B
$19.1M 0.02%
174,099
-216,097
-55% -$26.1M
XHB icon
628
State Street SPDR S&P Homebuilders ETF
XHB
$1.62B
$19M 0.02%
184,800
-43,860
-19% -$4.66M
PRA
629
DELISTED
ProAssurance
PRA
$19M 0.02%
787,265
+14,961
+2% +$360K
MRSH
630
Marsh
MRSH
$91.5B
$19M 0.02%
+102,435
New +$19.1M
CYBR
631
DELISTED
CyberArk
CYBR
$19M 0.02%
42,484
+16,970
+67% +$8.17M
ALGM icon
632
Allegro MicroSystems
ALGM
$8.16B
$18.9M 0.02%
714,579
+576,493
+417% +$15.9M
PTCT icon
633
PTC Therapeutics
PTCT
$6.12B
$18.8M 0.02%
247,746
+90,007
+57% +$6.54M
DAY
634
DELISTED
Dayforce
DAY
$18.8M 0.02%
271,325
+251,125
+1,243% +$17.3M
CFLT
635
DELISTED
Confluent
CFLT
$18.8M 0.02%
620,137
-111,765
-15% -$2.74M
TYRA icon
636
Tyra Biosciences
TYRA
$1.58B
$18.7M 0.02%
711,891
+109,876
+18% +$2.02M
GSK icon
637
GSK
GSK
$106B
$18.7M 0.02%
380,919
+317,030
+496% +$14.8M
BMRN icon
638
BioMarin Pharmaceuticals
BMRN
$12.4B
$18.5M 0.02%
+310,891
New +$16.9M
BORR
639
Borr Drilling
BORR
$1.19B
$18.4M 0.02%
4,573,837
+4,524,772
+9,222% +$15M
CDE icon
640
PUT
Coeur Mining
CDE
$17.9B
$18.2M 0.02%
+1,023,500
New +$17.8M
EWZ icon
641
iShares MSCI Brazil ETF
EWZ
$8.95B
$18.2M 0.02%
574,397
-810,617
-59% -$25.6M
HDB icon
642
HDFC Bank
HDB
$121B
$18.2M 0.02%
498,882
-1,883,072
-79% -$67.7M
HLIT icon
643
Harmonic Inc
HLIT
$1.28B
$18.2M 0.02%
1,842,139
-290,486
-14% -$2.93M
TRV icon
644
Travelers Companies
TRV
$80.2B
$18.2M 0.02%
+62,647
New +$17.6M
ARCC icon
645
Ares Capital
ARCC
$14.4B
$18.1M 0.02%
895,988
-914,055
-50% -$18.4M
ROP icon
646
Roper Technologies
ROP
$39.8B
$17.9M 0.02%
40,136
-39,514
-50% -$18.3M
FXI icon
647
iShares China Large-Cap ETF
FXI
$4.31B
$17.8M 0.02%
465,877
+196,100
+73% +$7.78M
ORCL icon
648
PUT
Oracle
ORCL
$423B
$17.7M 0.02%
91,000
+46,500
+104% +$11.1M
EQR icon
649
Equity Residential
EQR
$25.1B
$17.6M 0.02%
+279,623
New +$17.2M
PAYC icon
650
Paycom
PAYC
$9.69B
$17.6M 0.02%
+110,593
New +$19.6M

Similar funds

Marshall Wace's Q4 2025 Portfolio in Review

As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.

  • Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
  • Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
  • Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
  • Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
  • Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.